This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
All content for Empowered! is the property of Patient Empowerment Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
START HERE bridges the expert and patient voice, enabling chronic lymphocytic leukemia (CLL) patients to feel comfortable asking questions of their healthcare team with precision. In this program, CLL expert Dr. Danielle Brander speaks to managing CLL side effects, emerging novel CLL therapies and treatment options for CLL progression.Dr. Danielle Brander is an Assistant Professor in the Division of Hematologic Malignancies & Cellular Therapy at Duke University Medical Center. Learn more ...
Empowered!
This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
